These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6154082)

  • 1. Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues.
    Zarling JM; Schlais J; Eskra L; Greene JJ; Ts'o PO; Carter WA
    J Immunol; 1980 Apr; 124(4):1852-7. PubMed ID: 6154082
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double-stranded polynucleotides.
    Nolibe D; Aumaitre E; Thang MN
    Cancer Res; 1985 Oct; 45(10):4774-8. PubMed ID: 4027965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective immunosuppression in mice of natural killer cell activity by ochratoxin A.
    Luster MI; Germolec DR; Burleson GR; Jameson CW; Ackermann MF; Lamm KR; Hayes HT
    Cancer Res; 1987 May; 47(9):2259-63. PubMed ID: 2436759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):182-8. PubMed ID: 216746
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyinosinic acid-polycytidylic acid and its mismatched analogues: differential effects on human cell function.
    O'Malley JA; Leong SS; Horoszewicz JS; Carter WA; Alderfer JL; Ts'o PO
    Mol Pharmacol; 1979 Jan; 15(1):165-73. PubMed ID: 423886
    [No Abstract]   [Full Text] [Related]  

  • 9. Depressed natural killer activity in rheumatoid arthritis and its in vitro augmentation with interferon and N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA), an anti-arthritis agent.
    Itoh K; Saitoh F; Kumagai K; Kosaka S
    Ryumachi; 1981; 21 Suppl():69-74. PubMed ID: 6178171
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon and natural killer (NK) cells.
    Herberman RB; Ortaldo JR; Timonen T; Reynolds CW; Djeu JY; Pestka S; Stanton J
    Tex Rep Biol Med; 1981-1982; 41():590-5. PubMed ID: 6189224
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.
    Targan S; Dorey F
    J Immunol; 1980 May; 124(5):2157-61. PubMed ID: 6154092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.
    Kuribayashi K; Gillis S; Kern DE; Henney CS
    J Immunol; 1981 Jun; 126(6):2321-7. PubMed ID: 6164729
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
    Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
    In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon.
    Fresa KL; Korngold R; Murasko DM
    Cell Immunol; 1985 Apr; 91(2):336-43. PubMed ID: 2581698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
    Iigo M; Glazer RI
    Cancer Res; 1985 May; 45(5):1953-7. PubMed ID: 2580613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid-polycytidylic acid and its mismatched analogues.
    Ts'o PO; Alderfer JL; Levy J; Marshall LW; O'Malley J; Horoszewicz JS; Carter WA
    Mol Pharmacol; 1976 Mar; 12(2):299-312. PubMed ID: 1264072
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural killer (NK) cells.
    Herberman RB
    Prog Clin Biol Res; 1981; 58():33-43. PubMed ID: 6167995
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement by interferon of chicken splenocyte natural killer cell activity against Marek's disease tumor cells.
    Ding AH; Lam KM
    Vet Immunol Immunopathol; 1986 Jan; 11(1):65-72. PubMed ID: 2420060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.